Pilgrim's Pride Corporation - 10-Q Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended January 3, 2004 (14 weeks). Pilgrim's Pride Corporation is a producer of chicken and turkey products. The reporting period is significantly impacted by the acquisition of the ConAgra Foods, Inc. chicken division, completed on November 23, 2003, which has been included in results of operations since the acquisition date.
Key Financial Metrics
| Metric | Q1 2004 (14 weeks) | Q1 2003 (13 weeks) |
|---|---|---|
| Net Sales | $1,044.4 million | $627.4 million |
| Cost of Sales | $967.3 million | $599.4 million |
| Gross Margin | 7.4% | 6.7% |
| Operating Income | $30.8 million | $10.3 million |
| Net Income | $10.3 million | $2.8 million |
| Diluted EPS | $0.20 | $0.07 |
| Cash from Operations | $118.8 million | $40.6 million |
| Total Debt (Long-term + Current) | $725.7 million | $418.6 million |
| Cash and Equivalents | $98.1 million | $16.6 million |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 66.5% to $1.044 billion, driven primarily by the ConAgra acquisition which contributed approximately $259 million in sales (chicken and other products) during the quarter.
- Profitability: Operating income increased to $30.8 million from $10.3 million. The prior year period included $14.4 million in non-recurring recoveries (avian influenza and litigation settlements) which were absent in the current period.
- Balance Sheet Expansion: Total assets grew from $1.26 billion to $2.20 billion. Long-term debt increased significantly to fund the acquisition, rising from $416 million to $714 million (excluding current maturities).
- Segment Performance: U.S. Chicken operating income surged to $52.0 million from $4.0 million. Conversely, the Turkey segment reported an operating loss of $15.8 million, impacted by a 2002 Listeria recall and subsequent production cutbacks.
Outlook, Risks, and Management Commentary
- Acquisition Integration: Management is integrating the ConAgra division to realize cost savings and operational synergies. The final purchase price is subject to adjustment, with a potential $47 million reduction pending audit resolution.
- Turkey Segment Challenges: The company reduced turkey production by approximately 30% from 2002 levels to mitigate losses. Management estimates the Listeria recall will negatively impact operating margins by $20.0 to $25.0 million during the first six months of fiscal 2004.
- Market Risks: Earnings are sensitive to feed ingredient costs (corn, soybean meal), which represent ~30% of cost of goods sold. A hypothetical 10% increase in feed costs would raise cost of sales by approximately $37.8 million. Foreign exchange fluctuations in Mexico also pose a risk.
- Legal Contingencies: The company faces four lawsuits related to the 2002 Listeria recall and a new class-action complaint regarding racial and age discrimination at a ConAgra facility. Management believes insurance coverage and defenses will prevent material financial impact.
- Capital Structure: The company maintains a $400 million secured revolving/term facility and a $130 million revolving credit facility. Borrowings under the revolving facility were reduced by $27 million post-quarter-end.
Investor Verification Checklist
- Acquisition Accounting: Verify the final purchase price adjustment for the ConAgra deal and the potential $47 million asset reclassification.
- Turkey Recovery: Monitor the timeline for the Franconia, PA plant to return to pre-recall sales levels (projected for H2 2004) and the effectiveness of production cutbacks.
- Debt Servicing: Assess the impact of increased interest expense ($12.4 million vs $9.5 million prior year) on future cash flows given the higher leverage.
- Insurance Claims: Track the collection of the remaining insurance receivables related to the Listeria recall (total claim ~$100 million, policy limit $50 million).
- Feed Cost Hedging: Review future hedging strategies to mitigate volatility in corn and soybean meal prices.